[1] Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, Lombès M.
Mol Endocrinol. 2003 Dec;17(12):2529-42. [
PMID: 14500761]
[2] Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.
Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai-Takeda A, Saito I, Kitagawa H, Kato S, Saruta T, Itoh H.
J Biol Chem. 2007 Jan 19;282(3):1998-2010. [
PMID: 17105732]
[3] Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M, Almeida OF, Hutzler P, Melchior F, Michaelidis TM.
Mol Cell Endocrinol. 2007 Mar 30;268(1-2):20-9. [
PMID: 17314004]